Raleigh Capital Management Inc. Bio Rad Laboratories, Inc. Transaction History
Raleigh Capital Management Inc.
- $232 Million
- Q2 2024
A detailed history of Raleigh Capital Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 7 shares of BIO stock, worth $2,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 3
133.33%
Holding current value
$2,282
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BIO
# of Institutions
460Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$774 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$506 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$368 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$280 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$215 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.03B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...